Publications by authors named "Holly W Davis"

Claim this Profile
H
Halofuginone inhibits TGF-β/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis.
Patricia Juárez, Pierrick G J Fournier, Khalid S Mohammad, Ryan C McKenna, Holly W Davis

Oncotarget· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Halofuginone inhibits the establishment and progression of melanoma bone metastases.
Patricia Juárez, Khalid S Mohammad, Juan Juan Yin, Pierrick G J Fournier, Ryan C McKenna, Holly W Davis

Cancer Res· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment.
Lauren K Dunn, Khalid S Mohammad, Pierrick G J Fournier, C Ryan McKenna, Holly W Davis

PLoS One· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis